Once-weekly subcutaneous semaglutide in overweight and obese adults without diabetes | GPnotebook TV

This site is intended for UK healthcare professionals

GPnotebook ↗︎
GPnotebook Podcast ↗︎
blank
×

Once-weekly subcutaneous semaglutide in overweight and obese adults without diabetes

22 October 2021
Dr Anish Kotecha summarises a study into the use of the glucagon-like peptide-1 receptor agonist semaglutide, alongside a lifestyle intervention, to reduce weight.

Categories

Tags

blank

The content of this website is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. Any distribution or duplication of the information contained herein is strictly prohibited.

© Oxbridge Solutions Ltd, 2023

 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.